Landmesser Ulf, Spiekermann Stephan, Dikalov Sergey, Tatge Helma, Wilke Ragna, Kohler Christoph, Harrison David G, Hornig Burkhard, Drexler Helmut
Abteilung Kardiologie und Angiologie, Medizinische Hochschule Hannover, Hannover, Germany.
Circulation. 2002 Dec 10;106(24):3073-8. doi: 10.1161/01.cir.0000041431.57222.af.
Impaired flow-dependent, endothelium-mediated vasodilation (FDD) in patients with chronic heart failure (CHF) results, at least in part, from accelerated degradation of nitric oxide by oxygen radicals. The mechanisms leading to increased vascular radical formation, however, remain unclear. Therefore, we determined endothelium-bound activities of extracellular superoxide dismutase (ecSOD), a major vascular antioxidant enzyme, and xanthine-oxidase, a potent radical producing enzyme, and their relation to FDD in patients with CHF.
ecSOD and xanthine-oxidase activities, released from endothelium into plasma by heparin bolus injection, were determined in 14 patients with CHF and 10 control subjects. FDD of the radial artery was measured using high-resolution ultrasound and was assessed before and after administration of the antioxidant vitamin C (25 mg/min; IA). In patients with CHF, endothelium-bound ecSOD activity was substantially reduced (5.0+/-0.7 versus 14.4+/-2.6 U x mL(-1) x min(-1); P<0.01) and closely related to FDD (r=0.61). Endothelium-bound xanthine-oxidase activity was increased by >200% (38+/-10 versus 12+/-4 nmol O2*- x microL(-1); P<0.05) and inversely related to FDD (r=-0.35) in patients with CHF. In patients with low ecSOD and high xanthine-oxidase activity, a greater benefit of vitamin C on FDD was observed, ie, the portion of FDD inhibited by radicals correlated negatively with ecSOD (r=-0.71) but positively with xanthine-oxidase (r=0.75).
These results demonstrate that both increased xanthine-oxidase and reduced ecSOD activity are closely associated with increased vascular oxidative stress in patients with CHF. This loss of vascular oxidative balance likely represents a novel mechanism contributing to endothelial dysfunction in CHF.
慢性心力衰竭(CHF)患者中,血流依赖性、内皮介导的血管舒张功能(FDD)受损至少部分是由于氧自由基加速一氧化氮降解所致。然而,导致血管自由基生成增加的机制仍不清楚。因此,我们测定了细胞外超氧化物歧化酶(ecSOD,一种主要的血管抗氧化酶)和黄嘌呤氧化酶(一种强效的自由基生成酶)在内皮的活性,以及它们与CHF患者FDD的关系。
通过静脉推注肝素从内皮释放到血浆中的ecSOD和黄嘌呤氧化酶活性,在14例CHF患者和10例对照受试者中进行测定。使用高分辨率超声测量桡动脉的FDD,并在给予抗氧化剂维生素C(25mg/min;动脉内注射)前后进行评估。在CHF患者中,内皮结合的ecSOD活性显著降低(5.0±0.7对14.4±2.6U·mL⁻¹·min⁻¹;P<0.01),且与FDD密切相关(r=0.61)。CHF患者内皮结合的黄嘌呤氧化酶活性增加>200%(38±10对12±4nmol O₂⁻·μL⁻¹;P<0.05),且与FDD呈负相关(r=-0.35)。在ecSOD活性低和黄嘌呤氧化酶活性高的患者中,观察到维生素C对FDD有更大的益处,即自由基抑制的FDD部分与ecSOD呈负相关(r=-0.71),但与黄嘌呤氧化酶呈正相关(r=0.75)。
这些结果表明,黄嘌呤氧化酶增加和ecSOD活性降低均与CHF患者血管氧化应激增加密切相关。这种血管氧化平衡的丧失可能代表了导致CHF内皮功能障碍的一种新机制。